BioAscent Discovery

Website:
bioascent.com
Organisation type
Mr Christophe Auberger
Director of Business Development 
Mr James Hitchin
Vice President of Alliance Management 

C4X Discovery

Website:
c4xdiscovery.com
Organisation type
Dr Nick Ray
Chief Scientific Officer 
Dr Emma Thomas
Business & Corporate Development Manager 

Cell and Gene Therapy Catapult

The Cell and Gene Therapy Catapult is an independent innovation and technology organisation committed to the advancement of the CGT industry with a vision of a thriving industry delivering life changing advanced therapies to the world. Its aim is to create powerful collaborations which overcome challenges to the advancement of the sector. With over 400 experts covering all aspects of advanced therapies, it applies its unique capabilities and assets, collaborates with academia, industry and healthcare providers to develop new technology and innovation.

Organisation type
. .

Chromatin Bioscience

Website:
chromatinbio.com
Organisation type
Dr Michael Roberts
CEO 

Crystec

Organisation type
Mr Paul Thorning
CEO 

Cumulus Oncology

Organisation type
Dr Clare Wareing
Chief Executive Officer 

Domainex

Domainex is a multi-award-winning, integrated drug discovery service company that works collaboratively with clients from a variety of sectors (including pharmaceutical, biotechnology, academic and patient foundations) around the world. We offer a tailored and flexible approach and have expertise across a wide range of target classes, modalities (including covalent inhibitors and molecular glues) and therapeutic areas. Currently we have approximately 100 members of staff and offer the full range of pre-clinical drug discovery services including protein production, assay development and screening, hit identification (including fragment screening, virtual screening and high-throughput screening), medicinal and synthetic chemistry, structural biology (X-ray crystallography and Cryo-EM), bioanalytical services, ADME, hit-to-lead and lead optimisation. Domainex’s highly qualified and experienced team of dedicated research scientists has an unrivalled breadth of knowledge, access to a wide range of technologies and a proven track record of successful innovation in solving research challenges, including being named on numerous patent applications of candidate drugs. We aim to deliver successful outcomes efficiently and quickly, setting the highest possible benchmark in medicines research. We have an excellent reputation; >80% of our clients sign up for extensions or additional studies and >95% would recommend us to someone in their professional network. Full information about Domainex and its award-winning services can be found at www.domainex.co.uk. To speak to a representative or arrange a meeting, please contact us at enquiries@domainex.co.uk

About Domainex Ltd

Organisation type
. .

Evotec International

Website:
evotec.com
Organisation type
Ms Ninette van Lingen
SVP Business Development Biologics US East Coast 
Dr Bernd Muehlenweg
SVP, Head of Global Business Development, Cell Therapy 
Ms Itta MacNevin
SVP, Head of Business Development, North America 

hVIVO

Website:
hvivo.com/
Organisation type
. .

Intract Pharma

Organisation type
Dr Vipul Yadav
CEO